Logo image of EXPE

EXPEDIA GROUP INC (EXPE) Stock Fundamental Analysis

USA - NASDAQ:EXPE - US30212P3038 - Common Stock

224.98 USD
-3.26 (-1.43%)
Last: 9/16/2025, 8:15:14 PM
224.98 USD
0 (0%)
After Hours: 9/16/2025, 8:15:14 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EXPE. EXPE was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. While EXPE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EXPE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

EXPE had positive earnings in the past year.
EXPE had a positive operating cash flow in the past year.
In multiple years EXPE reported negative net income over the last 5 years.
Of the past 5 years EXPE 4 years had a positive operating cash flow.
EXPE Yearly Net Income VS EBIT VS OCF VS FCFEXPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

EXPE has a better Return On Assets (4.10%) than 60.15% of its industry peers.
EXPE has a better Return On Equity (132.42%) than 98.50% of its industry peers.
The Return On Invested Capital of EXPE (17.00%) is better than 85.71% of its industry peers.
EXPE had an Average Return On Invested Capital over the past 3 years of 10.99%. This is below the industry average of 15.68%.
The 3 year average ROIC (10.99%) for EXPE is below the current ROIC(17.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROIC 17%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
EXPE Yearly ROA, ROE, ROICEXPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

EXPE has a better Profit Margin (7.90%) than 66.17% of its industry peers.
EXPE's Profit Margin has improved in the last couple of years.
EXPE has a better Operating Margin (12.15%) than 64.66% of its industry peers.
EXPE's Operating Margin has improved in the last couple of years.
EXPE's Gross Margin of 89.58% is amongst the best of the industry. EXPE outperforms 97.74% of its industry peers.
In the last couple of years the Gross Margin of EXPE has grown nicely.
Industry RankSector Rank
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
EXPE Yearly Profit, Operating, Gross MarginsEXPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

EXPE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EXPE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EXPE has been reduced compared to 5 years ago.
Compared to 1 year ago, EXPE has an improved debt to assets ratio.
EXPE Yearly Shares OutstandingEXPE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPE Yearly Total Debt VS Total AssetsEXPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that EXPE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.19, EXPE is doing worse than 63.16% of the companies in the same industry.
EXPE has a debt to FCF ratio of 3.11. This is a good value and a sign of high solvency as EXPE would need 3.11 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.11, EXPE belongs to the best of the industry, outperforming 81.20% of the companies in the same industry.
A Debt/Equity ratio of 5.34 is on the high side and indicates that EXPE has dependencies on debt financing.
EXPE's Debt to Equity ratio of 5.34 is on the low side compared to the rest of the industry. EXPE is outperformed by 61.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Altman-Z 1.19
ROIC/WACC2.02
WACC8.41%
EXPE Yearly LT Debt VS Equity VS FCFEXPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

EXPE has a Current Ratio of 0.75. This is a bad value and indicates that EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.75, EXPE is doing worse than 60.15% of the companies in the same industry.
A Quick Ratio of 0.75 indicates that EXPE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.75, EXPE is in line with its industry, outperforming 45.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
EXPE Yearly Current Assets VS Current LiabilitesEXPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.29% over the past year.
Measured over the past years, EXPE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.87% on average per year.
Looking at the last year, EXPE shows a small growth in Revenue. The Revenue has grown by 5.69% in the last year.
Measured over the past years, EXPE shows a small growth in Revenue. The Revenue has been growing by 2.56% on average per year.
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%

3.2 Future

The Earnings Per Share is expected to grow by 15.50% on average over the next years. This is quite good.
Based on estimates for the next years, EXPE will show a small growth in Revenue. The Revenue will grow by 6.25% on average per year.
EPS Next Y18.05%
EPS Next 2Y17.92%
EPS Next 3Y17.55%
EPS Next 5Y15.5%
Revenue Next Year5.46%
Revenue Next 2Y5.98%
Revenue Next 3Y6.57%
Revenue Next 5Y6.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXPE Yearly Revenue VS EstimatesEXPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
EXPE Yearly EPS VS EstimatesEXPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.10, which indicates a rather expensive current valuation of EXPE.
Based on the Price/Earnings ratio, EXPE is valued a bit cheaper than 75.19% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, EXPE is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.22, which indicates a correct valuation of EXPE.
Based on the Price/Forward Earnings ratio, EXPE is valued a bit cheaper than 78.20% of the companies in the same industry.
EXPE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 17.1
Fwd PE 13.22
EXPE Price Earnings VS Forward Price EarningsEXPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXPE indicates a somewhat cheap valuation: EXPE is cheaper than 63.16% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPE indicates a rather cheap valuation: EXPE is cheaper than 85.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.94
EV/EBITDA 10.67
EXPE Per share dataEXPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EXPE's earnings are expected to grow with 17.55% in the coming years.
PEG (NY)0.95
PEG (5Y)1.15
EPS Next 2Y17.92%
EPS Next 3Y17.55%

3

5. Dividend

5.1 Amount

EXPE has a yearly dividend return of 0.72%, which is pretty low.
EXPE's Dividend Yield is a higher than the industry average which is at 3.93.
Compared to an average S&P500 Dividend Yield of 2.38, EXPE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.72%

5.2 History

EXPE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EXPE Yearly Dividends per shareEXPE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y17.92%
EPS Next 3Y17.55%
EXPE Yearly Income VS Free CF VS DividendEXPE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

NASDAQ:EXPE (9/16/2025, 8:15:14 PM)

After market: 224.98 0 (0%)

224.98

-3.26 (-1.43%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners100.21%
Inst Owner Change-1.57%
Ins Owners0.49%
Ins Owner Change0.27%
Market Cap27.83B
Analysts72.56
Price Target227.5 (1.12%)
Short Float %5.78%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield 0.72%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date08-28 2025-08-28 (0.4)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.21%
Min EPS beat(2)1.46%
Max EPS beat(2)20.96%
EPS beat(4)3
Avg EPS beat(4)9.14%
Min EPS beat(4)-0.95%
Max EPS beat(4)20.96%
EPS beat(8)7
Avg EPS beat(8)30.51%
EPS beat(12)8
Avg EPS beat(12)-12.48%
EPS beat(16)12
Avg EPS beat(16)3.75%
Revenue beat(2)1
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-2.83%
Max Revenue beat(2)0.11%
Revenue beat(4)2
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)1.66%
Revenue beat(8)3
Avg Revenue beat(8)-0.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.63%
PT rev (1m)14.23%
PT rev (3m)18.42%
EPS NQ rev (1m)-3.43%
EPS NQ rev (3m)0.5%
EPS NY rev (1m)2.13%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)1%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 17.1
Fwd PE 13.22
P/S 1.99
P/FCF 13.94
P/OCF 10.02
P/B 33.29
P/tB N/A
EV/EBITDA 10.67
EPS(TTM)13.16
EY5.85%
EPS(NY)17.02
Fwd EY7.56%
FCF(TTM)16.14
FCFY7.17%
OCF(TTM)22.45
OCFY9.98%
SpS113.3
BVpS6.76
TBVpS-55.12
PEG (NY)0.95
PEG (5Y)1.15
Profitability
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROCE 23.13%
ROIC 17%
ROICexc 181.1%
ROICexgc N/A
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
FCFM 14.25%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Debt/EBITDA 1.74
Cap/Depr 90.29%
Cap/Sales 5.57%
Interest Coverage 7.92
Cash Conversion 108.18%
Profit Quality 180.4%
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.19
F-Score8
WACC8.41%
ROIC/WACC2.02
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
EPS Next Y18.05%
EPS Next 2Y17.92%
EPS Next 3Y17.55%
EPS Next 5Y15.5%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%
Revenue Next Year5.46%
Revenue Next 2Y5.98%
Revenue Next 3Y6.57%
Revenue Next 5Y6.25%
EBIT growth 1Y7.31%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year134.06%
EBIT Next 3Y40.85%
EBIT Next 5Y27.05%
FCF growth 1Y-13.96%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y-11.08%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%